Business Context and Reporting Period
This Form 8-K Current Report was filed by Antero Midstream GP LP on April 26, 2018. The filing primarily addresses corporate governance changes, specifically the appointment of a new director to the Board of Directors of AMGP GP LLC (the General Partner) and the Partnership.
Key Financial Metrics
This filing does not contain financial performance data. There are no disclosures regarding revenue, profit, cash flow, margins, debt, or liquidity metrics in this document.
Material Changes
The material change reported is the appointment of Peter A. Dea to the Board of Directors, effective April 26, 2018. Key details include:
- Mr. Dea was appointed to serve until his death, resignation, or removal.
- He was immediately appointed to the Board's Audit Committee.
- The Board determined Mr. Dea meets independence requirements under New York Stock Exchange rules and the Partnership's standards.
- An Indemnification Agreement was entered into to protect Mr. Dea against liabilities arising from his service.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future business performance. No specific risks or contingencies were disclosed in this report, other than the standard legal protections outlined in the Indemnification Agreement.
Investor Verification Checklist
- Verify the full text of the Indemnification Agreement filed as Exhibit 10.1.
- Review the press release attached as Exhibit 99.1 for additional context on the appointment.
- Consult the Partnership's Annual Report on Form 10-K (filed February 13, 2018) for details on standard non-employee director compensation.
- Confirm that no other undisclosed transactions exist between the Partnership and Mr. Dea as per Item 404(a) of Regulation S-K.